Admin/Outreach Core
管理/外展核心
基本信息
- 批准号:8947587
- 负责人:
- 金额:$ 7.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdvocacyAdvocateBasic ScienceBiotechnologyBreastCaregiversCollaborationsCommunicationCommunitiesCommunity Health EducationDevelopmentDoctor of PhilosophyEnsureFosteringInstructionMonitorPatient EducationPatient advocacyPatientsPharmacologic SubstancePilot ProjectsPreventionQuality ControlRecruitment ActivityRegulationReport (document)ReportingResearchResearch PersonnelResearch SupportResourcesRoleSeriesSurvivorsThe Vanderbilt-Ingram Cancer Center at the Vanderbilt UniversityTrainingTravelcancer epidemiologycareer developmentmalignant breast neoplasmmeetingsoutreachprograms
项目摘要
The Administration & Outreach Core supports SPORE projects and investigators by managing SPORE
resources, quality control, and communication and outreach, including fostering interaction among SPORE
components and collaborators, other SPORES, the patient and advocate community, and the NCI. This
management and support is accomplished through a series of oversight committees and organized
administrative and scientific meetings of SPORE investigators, institutional representatives and external
advisors. Specific functions of the Core include:
• To administratively manage and coordinate all SPORE-related research
• To monitor and manage financial resources
• To create and prepare documents and reports to ensure compliance with federal regulations and
reporting requirements
• To administer the Developmental Research (pilot project) and Career Development Programs
• To organize all meetings, seminars, and travel related to Breast Cancer SPORE activities
• To serve as a point of contact to all VICC fundraising activities focused in breast cancer
• To support and coordinate all internal and external collaborations
• To serve as a main point of contact to biotechnology and pharmaceutical companies
Carlos L. Arteaga, MD, and Jane Kennedy, MSSW, will serve as co-Directors of the Core. Arteaga reports
directly to Jennifer Pietenpol, PhD, Director of VICC, and has input and assistance from the Deputy Director
(Daniel Beauchamp, MD) and the Associate Directors for Basic Science (Scott Hiebert, PhD) and Cancer
Epidemiology, Prevention & Control (William Blot, PhD). Arteaga provides advice to Dr. Pietenpol on
programmatic directions and allocation of VICC resources for research in breast cancer. Since 2006, Ms. Jane
Kennedy has served as Manager of Patient Advocacy in the VICC Office of Patient & Community Education
(OPACE). Ms. Kennedy's role includes recruiting, training and coordinating the survivors and caregivers who
contribute to and support the Research Advocacy Program of VICC, including the Breast SPORE.
管理和外展核心通过管理 SPORE 来支持 SPORE 项目和调查人员
资源、质量控制以及沟通和外展,包括促进 SPORE 之间的互动
成员和合作者、其他 SPORES、患者和倡导者社区以及 NCI。
管理和支持是通过一系列监督委员会完成的,并有组织的
SPORE 研究人员、机构代表和外部人员参加的行政和科学会议
核心的具体职能包括:
• 行政管理和协调所有与 SPORE 相关的研究
• 监控和管理财务资源
• 创建和准备文件和报告,以确保遵守联邦法规和
报告要求
• 管理发展研究(试点项目)和职业发展计划
• 组织与乳腺癌孢子活动相关的所有会议、研讨会和旅行
• 作为所有针对乳腺癌的 VICC 筹款活动的联络点
• 支持和协调所有内部和外部合作
• 作为生物技术和制药公司的主要联络点
Carlos L. Arteaga(医学博士)和 Jane Kennedy(MSSW)将担任 Arteaga 报告的联合主任。
直接联系 VICC 主任 Jennifer Pietenpol 博士,并得到副主任的意见和帮助
(Daniel Beauchamp,医学博士)以及基础科学和癌症副主任(Scott Hiebert,博士)
流行病学、预防和控制(William Blot 博士)向 Pietenpol 博士提供有关以下方面的建议。
Jane 女士自 2006 年起负责乳腺癌研究的规划方向和资源分配。
Kennedy 曾担任 VICC 患者和社区教育办公室的患者倡导经理
(OPACE) 肯尼迪女士的职责包括招募、培训和协调幸存者和护理人员。
为 VICC 的研究倡导计划(包括乳房孢子)做出贡献和支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carlos L Arteaga其他文献
Methods of Evaluating EGFR Expression The causal role of high expression of HER 2 in cancer
评估 EGFR 表达的方法 HER 2 高表达在癌症中的因果作用
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
Carlos L Arteaga - 通讯作者:
Carlos L Arteaga
Carlos L Arteaga的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carlos L Arteaga', 18)}}的其他基金
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
新辅助来那替尼治疗 I-III 期 HER2 突变小叶乳腺癌
- 批准号:
10660734 - 财政年份:2023
- 资助金额:
$ 7.77万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
9759820 - 财政年份:2018
- 资助金额:
$ 7.77万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
10214565 - 财政年份:2018
- 资助金额:
$ 7.77万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
10458531 - 财政年份:2018
- 资助金额:
$ 7.77万 - 项目类别:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
HER2 突变在乳腺癌进展和靶向治疗反应中的作用
- 批准号:
9614453 - 财政年份:2018
- 资助金额:
$ 7.77万 - 项目类别:
Inhibition of P13 Kinase as a Strategy to Abrogate Antiestrogen Resistance in Br
抑制 P13 激酶作为消除 Br 抗雌激素耐药性的策略
- 批准号:
8764757 - 财政年份:2014
- 资助金额:
$ 7.77万 - 项目类别:
UT Southwestern Medical Center Simmons Comprehensive Cancer Center
UT 西南医学中心西蒙斯综合癌症中心
- 批准号:
10693201 - 财政年份:2010
- 资助金额:
$ 7.77万 - 项目类别:
UT Southwestern Medical Center Simmons Comprehensive Cancer Center
UT 西南医学中心西蒙斯综合癌症中心
- 批准号:
10170609 - 财政年份:2010
- 资助金额:
$ 7.77万 - 项目类别:
相似海外基金
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
- 批准号:
10747566 - 财政年份:2023
- 资助金额:
$ 7.77万 - 项目类别:
Evaluation of Cancer Health Activism Network for Greater Equity (CHANGE)
癌症健康行动网络的评估以实现更大的公平(变更)
- 批准号:
10665478 - 财政年份:2023
- 资助金额:
$ 7.77万 - 项目类别:
SToP Cancer SPORE: Administrative Core A
STOP Cancer SPORE:行政核心 A
- 批准号:
10334082 - 财政年份:2022
- 资助金额:
$ 7.77万 - 项目类别:
SToP Cancer SPORE: Administrative Core A
STOP Cancer SPORE:行政核心 A
- 批准号:
10705565 - 财政年份:2022
- 资助金额:
$ 7.77万 - 项目类别: